Loading clinical trials...
Loading clinical trials...
A Phase 1b/2 Study of BMS-986442 in Combination With Nivolumab or Nivolumab and Chemotherapies in Participants With Advanced Solid Tumors and Non-small Cell Lung Cancer
Conditions
Interventions
BMS-986442
Nivolumab
+4 more
Locations
32
United States
Mayo Clinic in Arizona - Phoenix
Phoenix, Arizona, United States
Local Institution - 0096
Costa Mesa, California, United States
Local Institution - 0075
Orange, California, United States
Mayo Clinic in Florida
Jacksonville, Florida, United States
Local Institution - 0027
Orlando, Florida, United States
Local Institution - 0029
Fort Wayne, Indiana, United States
Start Date
October 4, 2022
Primary Completion Date
September 12, 2024
Completion Date
September 12, 2024
Last Updated
March 18, 2025
NCT07360314
NCT06758401
NCT07403721
NCT07431827
NCT06427941
NCT07164313
Lead Sponsor
Bristol-Myers Squibb
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions